Yukiko Ozawa
Narita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Chorea-acanthocytosis presenting with epilepsy at onset harboring novel compound heterozygous VPS13A mutations.
Journal: Clinical parkinsonism & related disorders
Published: December 30, 2025
Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis.
Journal: Journal of neuroimmunology
Published: December 03, 2025
Association between Myasthenia Gravis and Smoking.
Journal: Internal medicine (Tokyo, Japan)
Published: June 11, 2025
Corticosteroid-induced Cushingoid Appearance in Myasthenia Gravis.
Journal: Internal medicine (Tokyo, Japan)
Published: June 04, 2025
Emergence of Japanese encephalitis in a previously non-reported area: Three consecutive annual cases from a tertiary center in Narita, Chiba, Japan.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: February 22, 2025
Elevated serum levels of IL-10 family and IL-12 family cytokines in myasthenia gravis.
Journal: Journal of neuroimmunology
Published: January 20, 2025
Predicting achievement of clinical goals using machine learning in myasthenia gravis.
Journal: PloS one
Published: December 23, 2024
Corrigendum to "Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan" [Journal of Neuroimmunology 385 (2023) 578241].
Journal: Journal of neuroimmunology
Published: October 25, 2024
Elevated serum levels of C-terminal agrin fragment in acetylcholine receptor antibody-positive myasthenia gravis.
Journal: Journal of neuroimmunology
Published: July 04, 2024
Taste disorders and alopecia in myasthenia gravis.
Journal: BMC neurology
Published: December 30, 2023
Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan.
Journal: Journal of neuroimmunology
Published: September 25, 2023
Markedly upregulated serum semaphorin 4A as a novel activity marker of myasthenia gravis.
Journal: Scandinavian journal of immunology
Published: June 27, 2023
Last Updated: 09/26/2026